サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1780141

ヘパリンナトリウム原薬の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Heparin Sodium API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 97 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
ヘパリンナトリウム原薬の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年07月31日
発行: QYResearch
ページ情報: 英文 97 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ヘパリンナトリウム原薬 (Heparin Sodium API) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • ヘパリンナトリウム原薬 製品範囲
  • ヘパリンナトリウム原薬 タイプ別
    • 世界のヘパリンナトリウム原薬 販売：タイプ別 (2020 & 2024 & 2031)
    • Unfractionated Heparin Sodium
    • Low Molecular Heparin Sodium
  • ヘパリンナトリウム原薬 用途別
    • 世界のヘパリンナトリウム原薬 売上 比較：用途別 (2020 & 2024 & 2031)
    • Cardiovascular Disease
    • Dialysis Anticoagulation
    • Postoperative Thrombosis Prevention
    • Other
  • 世界のヘパリンナトリウム原薬 市場 推定および予測 (2020-2031)
    • 世界のヘパリンナトリウム原薬 市場規模 in 価格 成長率 (2020-2031)
    • Global Heparin Sodium API Market Size in Volume Growth Rate (2020-2031)
    • Global Heparin Sodium API Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界のヘパリンナトリウム原薬 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界のヘパリンナトリウム原薬 過去の市場分析：地域別 (2020-2025)
    • 世界のヘパリンナトリウム原薬の販売市場シェア 地域別 (2020-2025)
    • 世界のヘパリンナトリウム原薬の収益市場シェア 地域別 (2020-2025)
  • 世界のヘパリンナトリウム原薬 市場 推定および予測 地域別 (2026-2031)
    • 世界のヘパリンナトリウム原薬 売上予測・予想 地域別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米のヘパリンナトリウム原薬 市場規模および予測 (2020-2031)
    • 欧州のヘパリンナトリウム原薬 市場規模および予測 (2020-2031)
    • 中国のヘパリンナトリウム原薬 市場規模および予測 (2020-2031)
    • インド ヘパリンナトリウム原薬 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界のヘパリンナトリウム原薬の過去の市場概要：タイプ別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 販売：タイプ別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 収益：タイプ別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 価格：タイプ別 (2020-2025)
  • 世界のヘパリンナトリウム原薬の市場 推定および予測：タイプ別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の販売予測：タイプ別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の収益予測：タイプ別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の価格予測：タイプ別 (2026-2031)
  • 各種タイプ ヘパリンナトリウム原薬 代表的な企業

第4章 世界の市場規模：用途別

  • 世界のヘパリンナトリウム原薬の過去の市場概要：用途別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 販売：用途別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 収益：用途別 (2020-2025)
    • 世界のヘパリンナトリウム原薬 価格：用途別 (2020-2025)
  • 世界のヘパリンナトリウム原薬 市場 推定および予測：用途別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の販売予測：用途別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の収益予測：用途別 (2026-2031)
    • 世界のヘパリンナトリウム原薬の価格予測：用途別 (2026-2031)
  • 新たな成長源 ヘパリンナトリウム原薬 アプリケーション

第5章 競合他社の状況

  • 世界のヘパリンナトリウム原薬 売上 ：競合別 (2020-2025)
  • 世界のヘパリンナトリウム原薬の上位企業：収益別 (2020-2025)
  • 世界のヘパリンナトリウム原薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース ヘパリンナトリウム原薬 2024年)
  • 世界のヘパリンナトリウム原薬 企業別平均価格 (2020-2025)
  • 世界の主要メーカー ヘパリンナトリウム原薬, 製造拠点 & 本社
  • 世界の主要メーカー ヘパリンナトリウム原薬, 製品の種類・用途
  • 世界の主要メーカー ヘパリンナトリウム原薬, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米のヘパリンナトリウム原薬 売上：企業別
    • 北米のヘパリンナトリウム原薬 売上 内訳 タイプ別 (2020-2025)
    • 北米のヘパリンナトリウム原薬 売上構成比：用途別 (2020-2025)
    • 北米のヘパリンナトリウム原薬 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州のヘパリンナトリウム原薬 売上：企業別
    • 欧州のヘパリンナトリウム原薬 売上 内訳 タイプ別 (2020-2025)
    • 欧州のヘパリンナトリウム原薬 売上構成比：用途別 (2020-2025)
    • 欧州のヘパリンナトリウム原薬 主要顧客
    • 欧州の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国のヘパリンナトリウム原薬 売上：企業別
    • 中国のヘパリンナトリウム原薬 売上 内訳 タイプ別 (2020-2025)
    • 中国のヘパリンナトリウム原薬 売上構成比：用途別 (2020-2025)
    • 中国のヘパリンナトリウム原薬 主要顧客
    • 中国の市場 トレンドと機会
  • インド 市場: 参入企業、セグメント、下流、主要顧客
    • インド ヘパリンナトリウム原薬 売上：企業別
    • インド ヘパリンナトリウム原薬 売上 内訳 タイプ別 (2020-2025)
    • インド ヘパリンナトリウム原薬 売上構成比：用途別 (2020-2025)
    • インド ヘパリンナトリウム原薬 主要顧客
    • インド 市場 トレンドと機会

第7章 企業概要と主要企業

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

第8章 ヘパリンナトリウム原薬 製造コスト分析

  • ヘパリンナトリウム原薬 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： ヘパリンナトリウム原薬
  • ヘパリンナトリウム原薬 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • ヘパリンナトリウム原薬 販売代理店一覧
  • ヘパリンナトリウム原薬 顧客

第10章 ヘパリンナトリウム原薬 市場動向

  • ヘパリンナトリウム原薬 業界動向
  • ヘパリンナトリウム原薬 市場の促進要因
  • ヘパリンナトリウム原薬 市場の課題
  • ヘパリンナトリウム原薬 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Heparin Sodium API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Heparin Sodium API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Heparin Sodium API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Heparin Sodium API Sales (Kiloton) by Region (2020-2025)

Table 5. Global Heparin Sodium API Sales Market Share by Region (2020-2025)

Table 6. Global Heparin Sodium API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Heparin Sodium API Revenue Share by Region (2020-2025)

Table 8. Global Heparin Sodium API Sales (Kiloton) Forecast by Region (2026-2031)

Table 9. Global Heparin Sodium API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Heparin Sodium API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Heparin Sodium API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Heparin Sodium API Sales by Type (Kiloton) & (2020-2025)

Table 13. Global Heparin Sodium API Sales Share by Type (2020-2025)

Table 14. Global Heparin Sodium API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Heparin Sodium API Price by Type (US$/Ton) & (2020-2025)

Table 16. Global Heparin Sodium API Sales by Type (Kiloton) & (2026-2031)

Table 17. Global Heparin Sodium API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Heparin Sodium API Price by Type (US$/Ton) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Heparin Sodium API Sales by Application (Kiloton) & (2020-2025)

Table 21. Global Heparin Sodium API Sales Share by Application (2020-2025)

Table 22. Global Heparin Sodium API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Heparin Sodium API Price by Application (US$/Ton) & (2020-2025)

Table 24. Global Heparin Sodium API Sales by Application (Kiloton) & (2026-2031)

Table 25. Global Heparin Sodium API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Heparin Sodium API Price by Application (US$/Ton) & (2026-2031)

Table 27. New Sources of Growth in Heparin Sodium API Application

Table 28. Global Heparin Sodium API Sales by Company (Kiloton) & (2020-2025)

Table 29. Global Heparin Sodium API Sales Share by Company (2020-2025)

Table 30. Global Heparin Sodium API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Heparin Sodium API Revenue Share by Company (2020-2025)

Table 32. Global Heparin Sodium API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium API as of 2024)

Table 33. Global Market Heparin Sodium API Average Price by Company (US$/Ton) & (2020-2025)

Table 34. Global Key Manufacturers of Heparin Sodium API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Heparin Sodium API, Product Type & Application

Table 36. Global Key Manufacturers of Heparin Sodium API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Heparin Sodium API Sales by Company (2020-2025) & (Kiloton)

Table 39. North America Heparin Sodium API Sales Market Share by Company (2020-2025)

Table 40. North America Heparin Sodium API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Heparin Sodium API Revenue Market Share by Company (2020-2025)

Table 42. North America Heparin Sodium API Sales by Type (2020-2025) & (Kiloton)

Table 43. North America Heparin Sodium API Sales Market Share by Type (2020-2025)

Table 44. North America Heparin Sodium API Sales by Application (2020-2025) & (Kiloton)

Table 45. North America Heparin Sodium API Sales Market Share by Application (2020-2025)

Table 46. Europe Heparin Sodium API Sales by Company (2020-2025) & (Kiloton)

Table 47. Europe Heparin Sodium API Sales Market Share by Company (2020-2025)

Table 48. Europe Heparin Sodium API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Heparin Sodium API Revenue Market Share by Company (2020-2025)

Table 50. Europe Heparin Sodium API Sales by Type (2020-2025) & (Kiloton)

Table 51. Europe Heparin Sodium API Sales Market Share by Type (2020-2025)

Table 52. Europe Heparin Sodium API Sales by Application (2020-2025) & (Kiloton)

Table 53. Europe Heparin Sodium API Sales Market Share by Application (2020-2025)

Table 54. China Heparin Sodium API Sales by Company (2020-2025) & (Kiloton)

Table 55. China Heparin Sodium API Sales Market Share by Company (2020-2025)

Table 56. China Heparin Sodium API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Heparin Sodium API Revenue Market Share by Company (2020-2025)

Table 58. China Heparin Sodium API Sales by Type (2020-2025) & (Kiloton)

Table 59. China Heparin Sodium API Sales Market Share by Type (2020-2025)

Table 60. China Heparin Sodium API Sales by Application (2020-2025) & (Kiloton)

Table 61. China Heparin Sodium API Sales Market Share by Application (2020-2025)

Table 62. India Heparin Sodium API Sales by Company (2020-2025) & (Kiloton)

Table 63. India Heparin Sodium API Sales Market Share by Company (2020-2025)

Table 64. India Heparin Sodium API Revenue by Company (2020-2025) & (US$ Million)

Table 65. India Heparin Sodium API Revenue Market Share by Company (2020-2025)

Table 66. India Heparin Sodium API Sales by Type (2020-2025) & (Kiloton)

Table 67. India Heparin Sodium API Sales Market Share by Type (2020-2025)

Table 68. India Heparin Sodium API Sales by Application (2020-2025) & (Kiloton)

Table 69. India Heparin Sodium API Sales Market Share by Application (2020-2025)

Table 70. Shenzhen Hepalink Pharmaceutical Company Information

Table 71. Shenzhen Hepalink Pharmaceutical Description and Business Overview

Table 72. Shenzhen Hepalink Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Shenzhen Hepalink Pharmaceutical Heparin Sodium API Product

Table 74. Shenzhen Hepalink Pharmaceutical Recent Development

Table 75. Yantai Dongcheng Pharmaceutical Company Information

Table 76. Yantai Dongcheng Pharmaceutical Description and Business Overview

Table 77. Yantai Dongcheng Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Yantai Dongcheng Pharmaceutical Heparin Sodium API Product

Table 79. Yantai Dongcheng Pharmaceutical Recent Development

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Pfizer Heparin Sodium API Product

Table 84. Pfizer Recent Development

Table 85. Bioiberica Company Information

Table 86. Bioiberica Description and Business Overview

Table 87. Bioiberica Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Bioiberica Heparin Sodium API Product

Table 89. Bioiberica Recent Development

Table 90. Changzhou Qianhong Biopharma Company Information

Table 91. Changzhou Qianhong Biopharma Description and Business Overview

Table 92. Changzhou Qianhong Biopharma Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Changzhou Qianhong Biopharma Heparin Sodium API Product

Table 94. Changzhou Qianhong Biopharma Recent Development

Table 95. Nanjing King-friend Biochemical Pharmaceutical Company Information

Table 96. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview

Table 97. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Product

Table 99. Nanjing King-friend Biochemical Pharmaceutical Recent Development

Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information

Table 101. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview

Table 102. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Product

Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Development

Table 105. Qingdao Jiulong Biopharmaceutical Company Information

Table 106. Qingdao Jiulong Biopharmaceutical Description and Business Overview

Table 107. Qingdao Jiulong Biopharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Qingdao Jiulong Biopharmaceutical Heparin Sodium API Product

Table 109. Qingdao Jiulong Biopharmaceutical Recent Development

Table 110. Opocrin Company Information

Table 111. Opocrin Description and Business Overview

Table 112. Opocrin Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Opocrin Heparin Sodium API Product

Table 114. Opocrin Recent Development

Table 115. Dongying Tiandong Pharmaceutical Company Information

Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview

Table 117. Dongying Tiandong Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Dongying Tiandong Pharmaceutical Heparin Sodium API Product

Table 119. Dongying Tiandong Pharmaceutical Recent Development

Table 120. Aspen Oss Company Information

Table 121. Aspen Oss Description and Business Overview

Table 122. Aspen Oss Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Aspen Oss Heparin Sodium API Product

Table 124. Aspen Oss Recent Development

Table 125. Yino Pharma Company Information

Table 126. Yino Pharma Description and Business Overview

Table 127. Yino Pharma Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Yino Pharma Heparin Sodium API Product

Table 129. Yino Pharma Recent Development

Table 130. Nanjing Xinbai Pharmaceutical Company Information

Table 131. Nanjing Xinbai Pharmaceutical Description and Business Overview

Table 132. Nanjing Xinbai Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Nanjing Xinbai Pharmaceutical Heparin Sodium API Product

Table 134. Nanjing Xinbai Pharmaceutical Recent Development

Table 135. Hubei Enoray Biopharmaceutical Company Information

Table 136. Hubei Enoray Biopharmaceutical Description and Business Overview

Table 137. Hubei Enoray Biopharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. Hubei Enoray Biopharmaceutical Heparin Sodium API Product

Table 139. Hubei Enoray Biopharmaceutical Recent Development

Table 140. Cisen Pharmaceutical Company Information

Table 141. Cisen Pharmaceutical Description and Business Overview

Table 142. Cisen Pharmaceutical Heparin Sodium API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 143. Cisen Pharmaceutical Heparin Sodium API Product

Table 144. Cisen Pharmaceutical Recent Development

Table 145. Production Base and Market Concentration Rate of Raw Material

Table 146. Key Suppliers of Raw Materials

Table 147. Heparin Sodium API Distributors List

Table 148. Heparin Sodium API Customers List

Table 149. Heparin Sodium API Market Trends

Table 150. Heparin Sodium API Market Drivers

Table 151. Heparin Sodium API Market Challenges

Table 152. Heparin Sodium API Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Heparin Sodium API Product Picture

Figure 2. Global Heparin Sodium API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Heparin Sodium API Sales Market Share by Type in 2024 & 2031

Figure 4. Unfractionated Heparin Sodium Product Picture

Figure 5. Low Molecular Heparin Sodium Product Picture

Figure 6. Global Heparin Sodium API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Heparin Sodium API Sales Market Share by Application in 2024 & 2031

Figure 8. Cardiovascular Disease Examples

Figure 9. Dialysis Anticoagulation Examples

Figure 10. Postoperative Thrombosis Prevention Examples

Figure 11. Other Examples

Figure 12. Global Heparin Sodium API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Heparin Sodium API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Heparin Sodium API Sales (Kiloton) Growth Rate (2020-2031)

Figure 15. Global Heparin Sodium API Price Trends Growth Rate (2020-2031) & (US$/Ton)

Figure 16. Heparin Sodium API Report Years Considered

Figure 17. Global Market Heparin Sodium API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Heparin Sodium API Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Heparin Sodium API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Heparin Sodium API Sales (Kiloton) Growth Rate (2020-2031)

Figure 21. Europe Heparin Sodium API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Heparin Sodium API Sales (Kiloton) Growth Rate (2020-2031)

Figure 23. China Heparin Sodium API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Heparin Sodium API Sales (Kiloton) Growth Rate (2020-2031)

Figure 25. India Heparin Sodium API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. India Heparin Sodium API Sales (Kiloton) Growth Rate (2020-2031)

Figure 27. Global Heparin Sodium API Revenue Share by Type (2020-2025)

Figure 28. Global Heparin Sodium API Sales Share by Type (2026-2031)

Figure 29. Global Heparin Sodium API Revenue Share by Type (2026-2031)

Figure 30. Global Heparin Sodium API Revenue Share by Application (2020-2025)

Figure 31. Global Heparin Sodium API Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Heparin Sodium API Sales Share by Application (2026-2031)

Figure 33. Global Heparin Sodium API Revenue Share by Application (2026-2031)

Figure 34. Global Heparin Sodium API Sales Share by Company (2024)

Figure 35. Global Heparin Sodium API Revenue Share by Company (2024)

Figure 36. Global 5 Largest Heparin Sodium API Players Market Share by Revenue in Heparin Sodium API: 2020 & 2024

Figure 37. Heparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Heparin Sodium API

Figure 39. Manufacturing Process Analysis of Heparin Sodium API

Figure 40. Heparin Sodium API Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

目次

This research report focuses on the Heparin Sodium API Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Heparin Sodium API Product Scope
  • 1.2 Heparin Sodium API by Type
    • 1.2.1 Global Heparin Sodium API Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Unfractionated Heparin Sodium
    • 1.2.3 Low Molecular Heparin Sodium
  • 1.3 Heparin Sodium API by Application
    • 1.3.1 Global Heparin Sodium API Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 Cardiovascular Disease
    • 1.3.3 Dialysis Anticoagulation
    • 1.3.4 Postoperative Thrombosis Prevention
    • 1.3.5 Other
  • 1.4 Global Heparin Sodium API Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Heparin Sodium API Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Heparin Sodium API Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Heparin Sodium API Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Heparin Sodium API Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Heparin Sodium API Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Heparin Sodium API Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Heparin Sodium API Revenue Market Share by Region (2020-2025)
  • 2.3 Global Heparin Sodium API Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Heparin Sodium API Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Heparin Sodium API Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Heparin Sodium API Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Heparin Sodium API Market Size and Prospective (2020-2031)
    • 2.4.3 China Heparin Sodium API Market Size and Prospective (2020-2031)
    • 2.4.4 India Heparin Sodium API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Heparin Sodium API Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Heparin Sodium API Sales by Type (2020-2025)
    • 3.1.2 Global Heparin Sodium API Revenue by Type (2020-2025)
    • 3.1.3 Global Heparin Sodium API Price by Type (2020-2025)
  • 3.2 Global Heparin Sodium API Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Heparin Sodium API Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Heparin Sodium API Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Heparin Sodium API Price Forecast by Type (2026-2031)
  • 3.3 Different Types Heparin Sodium API Representative Players

4 Global Market Size by Application

  • 4.1 Global Heparin Sodium API Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Heparin Sodium API Sales by Application (2020-2025)
    • 4.1.2 Global Heparin Sodium API Revenue by Application (2020-2025)
    • 4.1.3 Global Heparin Sodium API Price by Application (2020-2025)
  • 4.2 Global Heparin Sodium API Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Heparin Sodium API Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Heparin Sodium API Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Heparin Sodium API Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Heparin Sodium API Application

5 Competition Landscape by Players

  • 5.1 Global Heparin Sodium API Sales by Players (2020-2025)
  • 5.2 Global Top Heparin Sodium API Players by Revenue (2020-2025)
  • 5.3 Global Heparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium API as of 2024)
  • 5.4 Global Heparin Sodium API Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Heparin Sodium API, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Heparin Sodium API, Product Type & Application
  • 5.7 Global Key Manufacturers of Heparin Sodium API, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Heparin Sodium API Sales by Company
      • 6.1.1.1 North America Heparin Sodium API Sales by Company (2020-2025)
      • 6.1.1.2 North America Heparin Sodium API Revenue by Company (2020-2025)
    • 6.1.2 North America Heparin Sodium API Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Heparin Sodium API Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Heparin Sodium API Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Heparin Sodium API Sales by Company
      • 6.2.1.1 Europe Heparin Sodium API Sales by Company (2020-2025)
      • 6.2.1.2 Europe Heparin Sodium API Revenue by Company (2020-2025)
    • 6.2.2 Europe Heparin Sodium API Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Heparin Sodium API Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Heparin Sodium API Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 China Heparin Sodium API Sales by Company
      • 6.3.1.1 China Heparin Sodium API Sales by Company (2020-2025)
      • 6.3.1.2 China Heparin Sodium API Revenue by Company (2020-2025)
    • 6.3.2 China Heparin Sodium API Sales Breakdown by Type (2020-2025)
    • 6.3.3 China Heparin Sodium API Sales Breakdown by Application (2020-2025)
    • 6.3.4 China Heparin Sodium API Major Customer
    • 6.3.5 China Market Trend and Opportunities
  • 6.4 India Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 India Heparin Sodium API Sales by Company
      • 6.4.1.1 India Heparin Sodium API Sales by Company (2020-2025)
      • 6.4.1.2 India Heparin Sodium API Revenue by Company (2020-2025)
    • 6.4.2 India Heparin Sodium API Sales Breakdown by Type (2020-2025)
    • 6.4.3 India Heparin Sodium API Sales Breakdown by Application (2020-2025)
    • 6.4.4 India Heparin Sodium API Major Customer
    • 6.4.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 Shenzhen Hepalink Pharmaceutical
    • 7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
    • 7.1.2 Shenzhen Hepalink Pharmaceutical Business Overview
    • 7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Products Offered
    • 7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
  • 7.2 Yantai Dongcheng Pharmaceutical
    • 7.2.1 Yantai Dongcheng Pharmaceutical Company Information
    • 7.2.2 Yantai Dongcheng Pharmaceutical Business Overview
    • 7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Yantai Dongcheng Pharmaceutical Heparin Sodium API Products Offered
    • 7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
  • 7.3 Pfizer
    • 7.3.1 Pfizer Company Information
    • 7.3.2 Pfizer Business Overview
    • 7.3.3 Pfizer Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Pfizer Heparin Sodium API Products Offered
    • 7.3.5 Pfizer Recent Development
  • 7.4 Bioiberica
    • 7.4.1 Bioiberica Company Information
    • 7.4.2 Bioiberica Business Overview
    • 7.4.3 Bioiberica Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 Bioiberica Heparin Sodium API Products Offered
    • 7.4.5 Bioiberica Recent Development
  • 7.5 Changzhou Qianhong Biopharma
    • 7.5.1 Changzhou Qianhong Biopharma Company Information
    • 7.5.2 Changzhou Qianhong Biopharma Business Overview
    • 7.5.3 Changzhou Qianhong Biopharma Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 Changzhou Qianhong Biopharma Heparin Sodium API Products Offered
    • 7.5.5 Changzhou Qianhong Biopharma Recent Development
  • 7.6 Nanjing King-friend Biochemical Pharmaceutical
    • 7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
    • 7.6.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
    • 7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Products Offered
    • 7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
  • 7.7 Hebei Changshan Biochemical Pharmaceutical
    • 7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
    • 7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
    • 7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Products Offered
    • 7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
  • 7.8 Qingdao Jiulong Biopharmaceutical
    • 7.8.1 Qingdao Jiulong Biopharmaceutical Company Information
    • 7.8.2 Qingdao Jiulong Biopharmaceutical Business Overview
    • 7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Products Offered
    • 7.8.5 Qingdao Jiulong Biopharmaceutical Recent Development
  • 7.9 Opocrin
    • 7.9.1 Opocrin Company Information
    • 7.9.2 Opocrin Business Overview
    • 7.9.3 Opocrin Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.9.4 Opocrin Heparin Sodium API Products Offered
    • 7.9.5 Opocrin Recent Development
  • 7.10 Dongying Tiandong Pharmaceutical
    • 7.10.1 Dongying Tiandong Pharmaceutical Company Information
    • 7.10.2 Dongying Tiandong Pharmaceutical Business Overview
    • 7.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium API Products Offered
    • 7.10.5 Dongying Tiandong Pharmaceutical Recent Development
  • 7.11 Aspen Oss
    • 7.11.1 Aspen Oss Company Information
    • 7.11.2 Aspen Oss Business Overview
    • 7.11.3 Aspen Oss Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.11.4 Aspen Oss Heparin Sodium API Products Offered
    • 7.11.5 Aspen Oss Recent Development
  • 7.12 Yino Pharma
    • 7.12.1 Yino Pharma Company Information
    • 7.12.2 Yino Pharma Business Overview
    • 7.12.3 Yino Pharma Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.12.4 Yino Pharma Heparin Sodium API Products Offered
    • 7.12.5 Yino Pharma Recent Development
  • 7.13 Nanjing Xinbai Pharmaceutical
    • 7.13.1 Nanjing Xinbai Pharmaceutical Company Information
    • 7.13.2 Nanjing Xinbai Pharmaceutical Business Overview
    • 7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.13.4 Nanjing Xinbai Pharmaceutical Heparin Sodium API Products Offered
    • 7.13.5 Nanjing Xinbai Pharmaceutical Recent Development
  • 7.14 Hubei Enoray Biopharmaceutical
    • 7.14.1 Hubei Enoray Biopharmaceutical Company Information
    • 7.14.2 Hubei Enoray Biopharmaceutical Business Overview
    • 7.14.3 Hubei Enoray Biopharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.14.4 Hubei Enoray Biopharmaceutical Heparin Sodium API Products Offered
    • 7.14.5 Hubei Enoray Biopharmaceutical Recent Development
  • 7.15 Cisen Pharmaceutical
    • 7.15.1 Cisen Pharmaceutical Company Information
    • 7.15.2 Cisen Pharmaceutical Business Overview
    • 7.15.3 Cisen Pharmaceutical Heparin Sodium API Sales, Revenue and Gross Margin (2020-2025)
    • 7.15.4 Cisen Pharmaceutical Heparin Sodium API Products Offered
    • 7.15.5 Cisen Pharmaceutical Recent Development

8 Heparin Sodium API Manufacturing Cost Analysis

  • 8.1 Heparin Sodium API Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Heparin Sodium API
  • 8.4 Heparin Sodium API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Heparin Sodium API Distributors List
  • 9.3 Heparin Sodium API Customers

10 Heparin Sodium API Market Dynamics

  • 10.1 Heparin Sodium API Industry Trends
  • 10.2 Heparin Sodium API Market Drivers
  • 10.3 Heparin Sodium API Market Challenges
  • 10.4 Heparin Sodium API Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer